Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors

[Image: see text] Covalent kinase inhibitors are rapidly emerging as a class of therapeutics with clinical benefits. Herein we report a series of selective 2-aminopyrimidine-based fibroblast growth factor receptor 4 (FGFR4) inhibitors exploring different types of cysteine-targeting warheads. The str...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Med Chem Lett
Autors principals: Deng, Wuqing, Chen, Xiaojuan, Jiang, Kaili, Song, Xiaojuan, Huang, Minhao, Tu, Zheng-Chao, Zhang, Zhang, Lin, Xiaojing, Ortega, Raquel, Patterson, Adam V., Smaill, Jeff B., Ding, Ke, Chen, Suming, Chen, Yongheng, Lu, Xiaoyun
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2021
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040253/
https://ncbi.nlm.nih.gov/pubmed/33859803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.1c00052
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars